Filed pursuant to Rule 497(a)

Registration No. 333-212142

Rule 482ad

 

Ares Capital Corporation
$600,000,000
4.250% Notes due 2025

 

PRICING TERM SHEET
January 8, 2018

 

The following sets forth the final terms of the 4.250% Notes due 2025 and should only be read together with the preliminary prospectus supplement dated January 8, 2018, together with the accompanying prospectus dated August 4, 2017, relating to these securities (the “Preliminary Prospectus”), and supersedes the information in the Preliminary Prospectus to the extent inconsistent with the information in the Preliminary Prospectus.  In all other respects, this pricing term sheet is qualified in its entirety by reference to the Preliminary Prospectus.  Terms used herein but not defined herein shall have the respective meanings as set forth in the Preliminary Prospectus.  All references to dollar amounts are references to U.S. dollars.

 

Issuer

Ares Capital Corporation

 

 

Security

4.250% Notes due 2025

 

 

Ratings*

BBB/BBB (Stable/Stable) (S&P/Fitch)

 

 

Aggregate Principal Amount Offered

$600,000,000

 

 

Maturity

March 1, 2025, unless earlier repurchased or redeemed

 

 

Trade Date

January 8, 2018

 

 

Price to Public (Issue Price)

99.621%

 

 

Coupon (Interest Rate)

4.250%

 

 

Yield to Maturity

4.311%

 

 

Spread to Benchmark Treasury

+190 basis points

 

 

Benchmark Treasury

2.250% due December 31, 2024

 

 

Benchmark Treasury Price and Yield

98-31 /2.411%

 

 

Interest Payment Dates

March 1 and September 1, commencing September 1, 2018

 



 

Make-Whole Redemption

Equal to the greater of the following amounts, plus, in each case, accrued and unpaid interest to the redemption date:

 

·                  100% of the principal amount of the notes to be redeemed, or

 

·                  the sum of the present values of the remaining scheduled payments of principal and interest (exclusive of accrued and unpaid interest to the date of redemption) on the notes to be redeemed, discounted to the redemption date on a semi-annual basis (assuming a 360-day year consisting of twelve 30-day months) using the applicable Treasury Rate plus 30 basis points; provided, however, that if Ares Capital redeems any Notes on or after January 1, 2025 (the date falling two months prior to the maturity date of the Notes), the redemption price for the Notes will be equal to 100% of the principal amount of the Notes to be redeemed, plus accrued and unpaid interest, if any, to, but excluding, the date of redemption.

 

 

Change of Control

Holders have the right to require Ares Capital to repurchase the notes at 100% of their principal amount plus accrued and unpaid interest, if any, in the event of a change of control repurchase event.

 

 

Settlement Date

January 11, 2018 (T+3)

 

 

Denomination

$2,000 and integral multiples of $1,000 in excess thereof

 

 

CUSIP

04010L AV5

 

 

ISIN

US04010LAV53

 

 

Joint Book-Running Managers

Merrill Lynch, Pierce, Fenner & Smith

Incorporated

Wells Fargo Securities, LLC

SunTrust Robinson Humphrey, Inc.

BMO Capital Markets, LLC

J.P. Morgan Securities LLC

SMBC Nikko Securities America, Inc.

 



 

Joint Lead Managers

Barclays Capital Inc.

Citigroup Global Markets Inc.

Goldman Sachs & Co. LLC

Mizuho Securities USA LLC

Morgan Stanley & Co. LLC

RBC Capital Markets, LLC

 

 

Co-Managers

Credit Suisse Securities (USA) LLC

MUFG Securities Americas Inc.

Santander Investment Securities Inc.

U.S. Bancorp Investments, Inc.

BNY Mellon Capital Markets, LLC

Capital One Securities, Inc.

Comerica Securities, Inc.

HSBC Securities (USA) Inc.

ICBC Standard Bank Plc

JMP Securities LLC

Keefe, Bruyette & Woods, Inc.

 


* Note: A securities rating is not a recommendation to buy, sell or hold securities and may be subject to revision or withdrawal at any time.

 

Ares Capital Corporation expects that delivery of the Notes will be made to investors on or about January 11, 2018, which will be the third business day following the date hereof. Under Rule 15c6-1 under the Securities Exchange Act of 1934, as amended, trades in the secondary market are required to settle in two business days, unless the parties to any such trade expressly agree otherwise. Accordingly, purchasers who wish to trade Notes on the date hereof will be required by virtue of the fact that the Notes initially settle in T+3, to specify an alternate settlement arrangement at the time of any such trade to prevent a failed settlement. Purchasers of the Notes who wish to trade the Notes on the date hereof should consult their advisors.

 

Investors are advised to carefully consider the investment objective, risks, charges and expenses of Ares Capital before investing.  The Preliminary Prospectus, which has been filed with the Securities and Exchange Commission, contains this and other information about Ares Capital and should be read carefully before investing.

 

The information in the Preliminary Prospectus and in this pricing term sheet is not complete and may be changed.  The Preliminary Prospectus and this pricing term sheet are not offers to sell any securities of Ares Capital and are not soliciting an offer to buy such securities in any jurisdiction where such offer and sale is not permitted.

 

A shelf registration statement relating to these securities is on file with and has been declared effective by the Securities and Exchange Commission.  The offering may be made only by means of a preliminary prospectus supplement and an accompanying prospectus.  Copies of the Preliminary Prospectus may be obtained from Merrill Lynch, Pierce, Fenner & Smith Incorporated, NC1-004-03-43, 200 North College Street, 3rd floor, Charlotte NC  28255-0001, Attn: Prospectus Department, or email dg.prospectus_requests@baml.com; Wells Fargo Securities, LLC, Attention: WFS Customer Service, 608 2nd Avenue, Suite 1000, Minneapolis, MN 55402, Attn: WFS

 



 

Customer Service, or by calling (800) 645-3751, or by email: wfscustomerservice@wellsfargo.com; or SunTrust Robinson Humphrey, Inc., 303 Peachtree Street, Atlanta, GA, 30308, Attn: Prospectus Department, or STRHdocs@SunTrust.com, or telephone: (800) 685-4786.